Gedeon Richter: Cariprazine shows effectiveness in the treatment of mental health disorders with combined substance use disorder

Gedeon Richter Plc. Austria Belgium France Germany Italy Netherlands Spain Switzerland Hungary United States of America United Kingdom California

for quantifying-visualizing symptom severity in patients with different psychiatric conditions.

Cariprazine is available in 67 countries globally, and the number of total patients treated from launch in Europe and US is around 1.700.000 (different indications).

About Richter

About Recordati

About Cariprazine

Media-contact: Zsuzsa Beke, Head of PR, [e-mail]

View original content:https://www.prnewswire.co.uk/news-releases/gedeon-richter-cariprazine-shows-effectiveness-in-the-treatment-of-mental-health-disorders-with-combined-substance-use-disorder-302423265.html